BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 9369421)

  • 21. Clinical impact of leukemic blast heterogeneity at diagnosis in cytogenetic intermediate-risk acute myeloid leukemia.
    Hoffmann MH; Klausen TW; Boegsted M; Larsen SF; Schmitz A; Leinoe EB; Schmiegelow K; Hasle H; Bergmann OJ; Sorensen S; Nyegaard M; Dybkaer K; Johnsen HE
    Cytometry B Clin Cytom; 2012 May; 82(3):123-31. PubMed ID: 22328535
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Immunophenotyping of eighty six children with acute lymphoblastic leukemia by three-color flow cytometry].
    Wan S; Gong W; Sun X; Xu J; Tian D
    Zhonghua Xue Ye Xue Za Zhi; 2002 Feb; 23(2):83-6. PubMed ID: 12015077
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monochromatic gating method by flow cytometry for high purity monocyte analysis.
    Wong L; Davis BH
    Cytometry B Clin Cytom; 2013 Mar; 84(2):119-24. PubMed ID: 23283833
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Side scatter versus CD45 flow cytometric plot can distinguish acute leukaemia subtypes.
    Saksena A; Gautam P; Desai P; Gupta N; Dubey AP; Singh T
    Indian J Med Res; 2016 May; 143(Supplement):S17-S22. PubMed ID: 27748273
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multicolor flow cytometric analysis of the CD45 antigen provides improved lymphoid cell discrimination in bone marrow and tissue biopsies.
    Festin R; Björkland A; Tötterman TH
    J Immunol Methods; 1994 Dec; 177(1-2):215-24. PubMed ID: 7822829
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Detection of minimal residual disease in B lineage acute lymphoblastic leukemia by 4-color flow cytometry].
    Liu YR; Wang H; Chang Y; Cheng YF; Fu JY; Zhang LP; Liu GL; Chen SS
    Zhonghua Xue Ye Xue Za Zhi; 2005 Jun; 26(6):327-31. PubMed ID: 16185473
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunological detection of blast cell subpopulations in acute myeloblastic leukemia at diagnosis: implications for minimal residual disease studies.
    Macedo A; Orfão A; Gonzalez M; Vidriales MB; López-Berges MC; Martínez A; San Miguel JF
    Leukemia; 1995 Jun; 9(6):993-8. PubMed ID: 7596191
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phenotypic quantitative features of patients with acute myeloid leukemia.
    Pereira FG; Metze K; Costa FP; Lima CS; Lorand-Metze I
    Neoplasma; 2006; 53(2):155-60. PubMed ID: 16575472
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myeloid enzymes profile related to the immunophenotypic characteristics of blast cells from patients with acute myeloid leukemia (AML) at diagnosis.
    Klobusicka M; Kusenda J; Babusikova O
    Neoplasma; 2005; 52(3):211-8. PubMed ID: 15875082
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gating strategy for immunophenotyping of leukemia and lymphoma.
    Sun T; Sangaline R; Ryder J; Gibbens K; Rollo C; Stewart S; Rajagopalan C
    Am J Clin Pathol; 1997 Aug; 108(2):152-7. PubMed ID: 9260755
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Flowcytometric-immunophenotyping for leukemia needs to be standardized].
    Chen SS
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Feb; 10(1):1-5. PubMed ID: 12513827
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Immunophenotyping of peripheral blood leukemic cells by multi-parameter cytometry].
    Zhang T; Zhao LL; Zhang CQ; Xu CG
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Mar; 20(2):225-7. PubMed ID: 15191732
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence, sensitivity, and specificity of leukemia-associated phenotypes in acute myeloid leukemia using specific five-color multiparameter flow cytometry.
    Al-Mawali A; Gillis D; Hissaria P; Lewis I
    Am J Clin Pathol; 2008 Jun; 129(6):934-45. PubMed ID: 18480011
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The value of multiparameter flow cytometry in diagnosis of lymphocytic leukemia and bone marrow involvement of non-Hodgkin's lymphoma].
    Sun XF; He LR; Feng HL; Yan SL; Xia ZJ; Chen XQ
    Ai Zheng; 2003 Nov; 22(11):1232-6. PubMed ID: 14613660
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Analysis of immunophenotype and leukemia associated immunophenotype in 610 patients with acute myeloid leukemia].
    Liu YR; Wang YZ; Chen SS; Chang Y; Fu JY; Li LD; Wang H; Yu H; Jiang B; Huang XJ
    Zhonghua Xue Ye Xue Za Zhi; 2007 Nov; 28(11):731-6. PubMed ID: 18457262
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Altered expression of CD45 isoforms in differentiation of acute myeloid leukemia.
    Miyachi H; Tanaka Y; Gondo K; Kawada T; Kato S; Sasao T; Hotta T; Oshima S; Ando Y
    Am J Hematol; 1999 Nov; 62(3):159-64. PubMed ID: 10539882
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
    Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
    Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of hairy cell leukaemia in blood and bone marrow using multidimensional flow cytometry with CD45-PECy5 and SS gating.
    Tytherleigh L; Taparia M; Leahy MF
    Clin Lab Haematol; 2001 Dec; 23(6):385-90. PubMed ID: 11843886
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A method comparison study of flow cytometry and cytomorphology to determine the percentages of blasts in patients with acute leukemia after induction and consolidation chemotherapy.
    Wongprajun S; Auewarakul CU
    J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S157-64. PubMed ID: 20364570
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Advantages of CD45 vs. side scatter based gating in the course of flow cytometric immuno-phenotyping in malignant hematologic diseases].
    Jáksó P; Pajor L
    Orv Hetil; 1998 Oct; 139(42):2509-13. PubMed ID: 9810165
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.